Viewing Study NCT06344169

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:51 PM
Ignite Modification Date: 2026-02-17 @ 5:47 PM
Study NCT ID: NCT06344169
Status: RECRUITING
Last Update Posted: 2025-05-09
First Post: 2024-03-27
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Dinalbuphine Ester (Naldebain) for Pain Management After Cesarean Section
Sponsor: Dalin Tzu Chi General Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Postsurgical Pain View
None Cesarean Section View
None Chronic Post-surgical Pain View
Keywords:

Keywords

Keyword Brief Keyword Text View
None kappa agonist View
None mu agonist View
None Intrathecal morphine View